<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Transverse Myelitis - Interactive Clinical Algorithm</title>
    <link href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.0.0/css/all.min.css" rel="stylesheet">
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif;
            background: linear-gradient(135deg, #f5f7fa 0%, #c3cfe2 100%);
            color: #2c3e50;
            line-height: 1.6;
            min-height: 100vh;
        }

        .header {
            background: linear-gradient(135deg, #1e3c72 0%, #2a5298 100%);
            color: white;
            padding: 2rem 2rem 1.5rem;
            text-align: center;
            box-shadow: 0 4px 20px rgba(0,0,0,0.15);
            position: relative;
            overflow: hidden;
        }

        .header::before {
            content: '';
            position: absolute;
            top: 0;
            left: 0;
            right: 0;
            bottom: 0;
            background: url("data:image/svg+xml,%3Csvg width='100' height='100' viewBox='0 0 100 100' xmlns='http://www.w3.org/2000/svg'%3E%3Cpath d='M11 18c3.866 0 7-3.134 7-7s-3.134-7-7-7-7 3.134-7 7 3.134 7 7 7zm48 25c3.866 0 7-3.134 7-7s-3.134-7-7-7-7 3.134-7 7 3.134 7 7 7zm-43-7c1.657 0 3-1.343 3-3s-1.343-3-3-3-3 1.343-3 3 1.343 3 3 3zm63 31c1.657 0 3-1.343 3-3s-1.343-3-3-3-3 1.343-3 3 1.343 3 3 3zM34 90c1.657 0 3-1.343 3-3s-1.343-3-3-3-3 1.343-3 3 1.343 3 3 3zm56-76c1.657 0 3-1.343 3-3s-1.343-3-3-3-3 1.343-3 3 1.343 3 3 3zM12 86c2.21 0 4-1.79 4-4s-1.79-4-4-4-4 1.79-4 4 1.79 4 4 4zm28-65c2.21 0 4-1.79 4-4s-1.79-4-4-4-4 1.79-4 4 1.79 4 4 4zm23-11c2.76 0 5-2.24 5-5s-2.24-5-5-5-5 2.24-5 5 2.24 5 5 5zm-6 60c2.21 0 4-1.79 4-4s-1.79-4-4-4-4 1.79-4 4 1.79 4 4 4zm29 22c2.76 0 5-2.24 5-5s-2.24-5-5-5-5 2.24-5 5 2.24 5 5 5zM32 63c2.21 0 4-1.79 4-4s-1.79-4-4-4-4 1.79-4 4 1.79 4 4 4zm57-13c2.76 0 5-2.24 5-5s-2.24-5-5-5-5 2.24-5 5 2.24 5 5 5zm-9-21c1.105 0 2-.895 2-2s-.895-2-2-2-2 .895-2 2 .895 2 2 2zM60 91c1.105 0 2-.895 2-2s-.895-2-2-2-2 .895-2 2 .895 2 2 2zM35 41c1.105 0 2-.895 2-2s-.895-2-2-2-2 .895-2 2 .895 2 2 2zM12 60c1.105 0 2-.895 2-2s-.895-2-2-2-2 .895-2 2 .895 2 2 2z' fill='%23ffffff' fill-opacity='0.05' fill-rule='evenodd'/%3E%3C/svg%3E");
            opacity: 0.1;
        }

        .header h1 {
            font-size: 2.5rem;
            font-weight: 700;
            margin-bottom: 0.5rem;
            position: relative;
            text-shadow: 0 2px 4px rgba(0,0,0,0.2);
        }

        .header p {
            font-size: 1.1rem;
            opacity: 0.9;
            position: relative;
        }

        .container {
            display: flex;
            max-width: 1400px;
            margin: 0 auto;
            min-height: calc(100vh - 120px);
        }

        .sidebar {
            width: 280px;
            background: white;
            box-shadow: 2px 0 15px rgba(0,0,0,0.1);
            position: sticky;
            top: 0;
            height: 100vh;
            overflow-y: auto;
            padding: 2rem 1.5rem;
            z-index: 100;
        }

        .sidebar h3 {
            color: #2c3e50;
            margin-bottom: 1.5rem;
            font-size: 1.3rem;
            font-weight: 600;
            display: flex;
            align-items: center;
            gap: 0.5rem;
        }

        .progress-item {
            display: flex;
            align-items: center;
            padding: 0.75rem 1rem;
            margin-bottom: 0.5rem;
            border-radius: 8px;
            cursor: pointer;
            transition: all 0.3s ease;
            color: #7f8c8d;
            font-weight: 500;
        }

        .progress-item:hover {
            background: #f8f9fa;
            transform: translateX(5px);
        }

        .progress-item.active {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            box-shadow: 0 4px 12px rgba(102, 126, 234, 0.4);
        }

        .progress-item.completed {
            background: #e8f5e9;
            color: #2e7d32;
        }

        .progress-icon {
            width: 24px;
            height: 24px;
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            margin-right: 0.75rem;
            font-size: 0.8rem;
            font-weight: bold;
        }

        .progress-item.active .progress-icon {
            background: rgba(255,255,255,0.2);
        }

        .progress-item.completed .progress-icon {
            background: #4caf50;
            color: white;
        }

        .progress-item:not(.active):not(.completed) .progress-icon {
            background: #e0e0e0;
            color: #9e9e9e;
        }

        .main-content {
            flex: 1;
            padding: 2rem;
            margin-left: 280px;
        }

        .card {
            background: white;
            border-radius: 16px;
            box-shadow: 0 8px 30px rgba(0,0,0,0.12);
            margin-bottom: 2rem;
            overflow: hidden;
            transition: all 0.4s cubic-bezier(0.175, 0.885, 0.32, 1.275);
            border: 1px solid rgba(0,0,0,0.05);
        }

        .card:hover {
            transform: translateY(-5px);
            box-shadow: 0 12px 40px rgba(0,0,0,0.15);
        }

        .card-header {
            padding: 1.75rem 2rem;
            color: white;
            font-size: 1.4rem;
            font-weight: 600;
            display: flex;
            align-items: center;
            justify-content: space-between;
            cursor: pointer;
            transition: all 0.3s ease;
            position: relative;
            overflow: hidden;
        }

        .card-header::after {
            content: '';
            position: absolute;
            top: 0;
            left: 0;
            right: 0;
            bottom: 0;
            background: linear-gradient(45deg, rgba(255,255,255,0.1) 0%, transparent 100%);
            opacity: 0.5;
        }

        .card-header.assessment {
            background: linear-gradient(135deg, #3498db 0%, #2980b9 100%);
        }

        .card-header.diagnosis {
            background: linear-gradient(135deg, #9b59b6 0%, #8e44ad 100%);
        }

        .card-header.treatment {
            background: linear-gradient(135deg, #2ecc71 0%, #27ae60 100%);
        }

        .card-header.followup {
            background: linear-gradient(135deg, #f39c12 0%, #e67e22 100%);
        }

        .card-header i {
            font-size: 1.8rem;
            margin-right: 1rem;
            position: relative;
            z-index: 1;
        }

        .card-header span {
            position: relative;
            z-index: 1;
        }

        .expand-icon {
            transition: transform 0.3s ease;
            position: relative;
            z-index: 1;
        }

        .card.expanded .expand-icon {
            transform: rotate(180deg);
        }

        .card-body {
            max-height: 0;
            overflow: hidden;
            transition: max-height 0.4s ease;
        }

        .card.expanded .card-body {
            max-height: 3000px;
        }

        .card-content {
            padding: 2rem;
        }

        .section {
            margin-bottom: 2rem;
        }

        .section-title {
            font-size: 1.2rem;
            font-weight: 600;
            color: #2c3e50;
            margin-bottom: 1rem;
            display: flex;
            align-items: center;
            gap: 0.5rem;
        }

        .badge {
            display: inline-block;
            padding: 0.25rem 0.75rem;
            border-radius: 20px;
            font-size: 0.75rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.5px;
            margin-left: 0.5rem;
        }

        .badge-urgent {
            background: linear-gradient(135deg, #e74c3c 0%, #c0392b 100%);
            color: white;
            box-shadow: 0 2px 8px rgba(231, 76, 60, 0.3);
        }

        .badge-caution {
            background: linear-gradient(135deg, #f1c40f 0%, #f39c12 100%);
            color: #2c3e50;
            box-shadow: 0 2px 8px rgba(241, 196, 15, 0.3);
        }

        .badge-stable {
            background: linear-gradient(135deg, #2ecc71 0%, #27ae60 100%);
            color: white;
            box-shadow: 0 2px 8px rgba(46, 204, 113, 0.3);
        }

        .list-item {
            background: #f8f9fa;
            padding: 1rem;
            margin-bottom: 0.75rem;
            border-radius: 10px;
            border-left: 4px solid #3498db;
            transition: all 0.3s ease;
            position: relative;
            overflow: hidden;
        }

        .list-item:hover {
            background: #e3f2fd;
            transform: translateX(5px);
        }

        .list-item::before {
            content: '';
            position: absolute;
            top: 0;
            left: 0;
            bottom: 0;
            width: 0;
            background: #3498db;
            transition: width 0.3s ease;
            z-index: 0;
        }

        .list-item:hover::before {
            width: 4px;
        }

        .list-item-content {
            position: relative;
            z-index: 1;
        }

        .list-item strong {
            color: #2c3e50;
            display: block;
            margin-bottom: 0.25rem;
        }

        .criteria-box {
            background: linear-gradient(135deg, #e3f2fd 0%, #bbdefb 100%);
            border: 1px solid #90caf9;
            border-radius: 12px;
            padding: 1.5rem;
            margin: 1rem 0;
            position: relative;
            overflow: hidden;
        }

        .criteria-box::before {
            content: '';
            position: absolute;
            top: 0;
            left: 0;
            right: 0;
            bottom: 0;
            background: url("data:image/svg+xml,%3Csvg width='60' height='60' viewBox='0 0 60 60' xmlns='http://www.w3.org/2000/svg'%3E%3Cg fill='none' fill-rule='evenodd'%3E%3Cg fill='%234fc3f7' fill-opacity='0.1'%3E%3Cpath d='M36 34v-4h-2v4h-4v2h4v4h2v-4h4v-2h-4zm0-30V0h-2v4h-4v2h4v4h2V6h4V4h-4zM6 34v-4H4v4H0v2h4v4h2v-4h4v-2H6zM6 4V0H4v4H0v2h4v4h2V6h4V4H6z'/%3E%3C/g%3E%3C/g%3E%3C/svg%3E");
            opacity: 0.3;
        }

        .criteria-title {
            font-weight: 700;
            color: #1565c0;
            margin-bottom: 1rem;
            font-size: 1.1rem;
            position: relative;
        }

        .criteria-list {
            list-style: none;
            padding-left: 0;
        }

        .criteria-list li {
            padding: 0.5rem 0;
            padding-left: 1.5rem;
            position: relative;
        }

        .criteria-list li::before {
            content: '▸';
            position: absolute;
            left: 0;
            color: #1976d2;
            font-weight: bold;
        }

        .treatment-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(300px, 1fr));
            gap: 1.5rem;
            margin: 1.5rem 0;
        }

        .treatment-card {
            background: white;
            border-radius: 12px;
            padding: 1.5rem;
            box-shadow: 0 4px 15px rgba(0,0,0,0.08);
            border: 1px solid #e0e0e0;
            transition: all 0.3s ease;
            position: relative;
            overflow: hidden;
        }

        .treatment-card:hover {
            transform: translateY(-3px);
            box-shadow: 0 8px 25px rgba(0,0,0,0.12);
        }

        .treatment-card::after {
            content: '';
            position: absolute;
            top: 0;
            left: 0;
            right: 0;
            height: 4px;
            background: linear-gradient(90deg, #2ecc71, #27ae60);
            opacity: 0.7;
        }

        .treatment-card h4 {
            color: #2c3e50;
            margin-bottom: 1rem;
            font-size: 1.1rem;
        }

        .treatment-card ul {
            list-style: none;
            padding: 0;
        }

        .treatment-card li {
            padding: 0.5rem 0;
            border-bottom: 1px solid #f0f0f0;
            font-size: 0.95rem;
        }

        .treatment-card li:last-child {
            border-bottom: none;
        }

        .medication-item {
            background: #f1f8e9;
            border: 1px solid #c5e1a5;
            padding: 1rem;
            border-radius: 8px;
            margin-bottom: 0.75rem;
        }

        .medication-name {
            font-weight: 700;
            color: #33691e;
            display: block;
            margin-bottom: 0.25rem;
        }

        .medication-dose {
            font-size: 0.9rem;
            color: #558b2f;
        }

        .warning-box {
            background: linear-gradient(135deg, #fff3e0 0%, #ffe0b2 100%);
            border: 1px solid #ffcc80;
            border-radius: 10px;
            padding: 1rem;
            margin: 1rem 0;
            display: flex;
            align-items: flex-start;
            gap: 0.75rem;
            position: relative;
            overflow: hidden;
        }

        .warning-box::before {
            content: '';
            position: absolute;
            top: 0;
            left: 0;
            right: 0;
            bottom: 0;
            background: url("data:image/svg+xml,%3Csvg width='100' height='100' viewBox='0 0 100 100' xmlns='http://www.w3.org/2000/svg'%3E%3Cpath d='M11 18c3.866 0 7-3.134 7-7s-3.134-7-7-7-7 3.134-7 7 3.134 7 7 7zm48 25c3.866 0 7-3.134 7-7s-3.134-7-7-7-7 3.134-7 7 3.134 7 7 7zm-43-7c1.657 0 3-1.343 3-3s-1.343-3-3-3-3 1.343-3 3 1.343 3 3 3zm63 31c1.657 0 3-1.343 3-3s-1.343-3-3-3-3 1.343-3 3 1.343 3 3 3zM34 90c1.657 0 3-1.343 3-3s-1.343-3-3-3-3 1.343-3 3 1.343 3 3 3zm56-76c1.657 0 3-1.343 3-3s-1.343-3-3-3-3 1.343-3 3 1.343 3 3 3zM12 86c2.21 0 4-1.79 4-4s-1.79-4-4-4-4 1.79-4 4 1.79 4 4 4zm28-65c2.21 0 4-1.79 4-4s-1.79-4-4-4-4 1.79-4 4 1.79 4 4 4zm23-11c2.76 0 5-2.24 5-5s-2.24-5-5-5-5 2.24-5 5 2.24 5 5 5zm-6 60c2.21 0 4-1.79 4-4s-1.79-4-4-4-4 1.79-4 4 1.79 4 4 4zm29 22c2.76 0 5-2.24 5-5s-2.24-5-5-5-5 2.24-5 5 2.24 5 5 5zM32 63c2.21 0 4-1.79 4-4s-1.79-4-4-4-4 1.79-4 4 1.79 4 4 4zm57-13c2.76 0 5-2.24 5-5s-2.24-5-5-5-5 2.24-5 5 2.24 5 5 5zm-9-21c1.105 0 2-.895 2-2s-.895-2-2-2-2 .895-2 2 .895 2 2 2zM60 91c1.105 0 2-.895 2-2s-.895-2-2-2-2 .895-2 2 .895 2 2 2zM35 41c1.105 0 2-.895 2-2s-.895-2-2-2-2 .895-2 2 .895 2 2 2zM12 60c1.105 0 2-.895 2-2s-.895-2-2-2-2 .895-2 2 .895 2 2 2z' fill='%23ff9800' fill-opacity='0.1' fill-rule='evenodd'/%3E%3C/svg%3E");
            opacity: 0.3;
        }

        .warning-icon {
            color: #f57c00;
            font-size: 1.2rem;
            flex-shrink: 0;
            position: relative;
            z-index: 1;
        }

        .warning-content {
            position: relative;
            z-index: 1;
        }

        .warning-content strong {
            color: #e65100;
            display: block;
            margin-bottom: 0.25rem;
        }

        .footer {
            background: #2c3e50;
            color: white;
            text-align: center;
            padding: 2rem;
            margin-top: 3rem;
        }

        .footer p {
            margin-bottom: 0.5rem;
            opacity: 0.8;
        }

        .footer a {
            color: #3498db;
            text-decoration: none;
        }

        .footer a:hover {
            text-decoration: underline;
        }

        @media (max-width: 1024px) {
            .container {
                flex-direction: column;
            }

            .sidebar {
                width: 100%;
                height: auto;
                position: relative;
                padding: 1.5rem;
            }

            .main-content {
                margin-left: 0;
                padding: 1.5rem;
            }

            .header h1 {
                font-size: 2rem;
            }

            .treatment-grid {
                grid-template-columns: 1fr;
            }
        }

        @media (max-width: 768px) {
            .header h1 {
                font-size: 1.8rem;
            }

            .card-content {
                padding: 1.5rem;
            }

            .card-header {
                padding: 1.25rem 1.5rem;
            }
        }

        .fade-in {
            animation: fadeIn 0.6s ease-in;
        }

        @keyframes fadeIn {
            from { opacity: 0; transform: translateY(20px); }
            to { opacity: 1; transform: translateY(0); }
        }

        .pulse {
            animation: pulse 2s infinite;
        }

        @keyframes pulse {
            0% { box-shadow: 0 0 0 0 rgba(231, 76, 60, 0.4); }
            70% { box-shadow: 0 0 0 10px rgba(231, 76, 60, 0); }
            100% { box-shadow: 0 0 0 0 rgba(231, 76, 60, 0); }
        }
    </style>
</head>
<body>
    <div class="header">
        <h1><i class="fas fa-brain"></i> Transverse Myelitis</h1>
        <p>Interactive Clinical Decision Support Algorithm | Based on BMJ Best Practice Guidelines</p>
    </div>

    <div class="container">
        <aside class="sidebar">
            <h3><i class="fas fa-route"></i> Algorithm Progress</h3>
            <div class="progress-item active" data-step="assessment">
                <div class="progress-icon">1</div>
                <div>Assessment</div>
            </div>
            <div class="progress-item" data-step="diagnosis">
                <div class="progress-icon">2</div>
                <div>Diagnosis</div>
            </div>
            <div class="progress-item" data-step="treatment">
                <div class="progress-icon">3</div>
                <div>Treatment</div>
            </div>
            <div class="progress-item" data-step="followup">
                <div class="progress-icon">4</div>
                <div>Follow-up</div>
            </div>
        </aside>

        <main class="main-content">
            <!-- Assessment Card -->
            <div class="card fade-in" id="assessment-card">
                <div class="card-header assessment" onclick="toggleCard('assessment')">
                    <div style="display: flex; align-items: center;">
                        <i class="fas fa-clipboard-check"></i>
                        <span>Assessment</span>
                    </div>
                    <i class="fas fa-chevron-down expand-icon"></i>
                </div>
                <div class="card-body">
                    <div class="card-content">
                        <div class="section">
                            <div class="section-title">
                                <i class="fas fa-exclamation-triangle"></i>
                                Key Clinical Features
                                <span class="badge badge-urgent">Acute Presentation</span>
                            </div>
                            <div class="list-item">
                                <div class="list-item-content">
                                    <strong>Motor Weakness</strong>
                                    Progressive paraparesis/quadriparesis following pyramidal pattern, with upper motor neuron signs
                                </div>
                            </div>
                            <div class="list-item">
                                <div class="list-item-content">
                                    <strong>Sensory Impairment</strong>
                                    Ascending paresthesias with sensory level below lesion, loss of vibration/proprioception
                                </div>
                            </div>
                            <div class="list-item">
                                <div class="list-item-content">
                                    <strong>Autonomic Dysfunction</strong>
                                    Urinary/bowel incontinence or retention (>60% of patients)
                                </div>
                            </div>
                            <div class="list-item">
                                <div class="list-item-content">
                                    <strong>Pain</strong>
                                    Mid-line back pain at lesion level, radicular or segmental pain
                                </div>
                            </div>
                        </div>

                        <div class="section">
                            <div class="section-title">
                                <i class="fas fa-history"></i>
                                History & Risk Factors
                                <span class="badge badge-caution">Recent Events</span>
                            </div>
                            <div class="list-item">
                                <div class="list-item-content">
                                    <strong>Preceding Infection</strong>
                                    Systemic viral illness within 1-4 weeks prior to onset (>50% of patients)
                                </div>
                            </div>
                            <div class="list-item">
                                <div class="list-item-content">
                                    <strong>Recent Vaccination</strong>
                                    Post-immunization myelitis reported with almost all vaccines
                                </div>
                            </div>
                            <div class="list-item">
                                <div class="list-item-content">
                                    <strong>Demographics</strong>
                                    Bimodal age distribution (10-19 years, 30-39 years), female predominance
                                </div>
                            </div>
                        </div>

                        <div class="section">
                            <div class="section-title">
                                <i class="fas fa-search"></i>
                                Critical First Step
                                <span class="badge badge-urgent">URGENT</span>
                            </div>
                            <div class="warning-box">
                                <i class="fas fa-exclamation-triangle warning-icon"></i>
                                <div class="warning-content">
                                    <strong>Exclude Compressive Myelopathy</strong>
                                    MRI of entire spinal cord required to rule out compression, neoplasm, or abscess
                                </div>
                            </div>
                        </div>

                        <div class="section">
                            <div class="section-title">
                                <i class="fas fa-stethoscope"></i>
                                Clinical Syndromes
                            </div>
                            <div class="treatment-grid">
                                <div class="treatment-card">
                                    <h4><i class="fas fa-balance-scale"></i> Partial Cord Syndrome</h4>
                                    <ul>
                                        <li>Asymmetric lesions (1-2 segments)</li>
                                        <li>Brown-Séquard pattern suggests MS</li>
                                        <li>Mild to moderate severity</li>
                                    </ul>
                                </div>
                                <div class="treatment-card">
                                    <h4><i class="fas fa-arrows-alt-v"></i> Complete Cord Syndrome</h4>
                                    <ul>
                                        <li>Longitudinally extensive (≥3 segments)</li>
                                        <li>Bilateral, symmetric symptoms</li>
                                        <li>Moderate to severe deficits</li>
                                    </ul>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
            </div>

            <!-- Diagnosis Card -->
            <div class="card fade-in" id="diagnosis-card">
                <div class="card-header diagnosis" onclick="toggleCard('diagnosis')">
                    <div style="display: flex; align-items: center;">
                        <i class="fas fa-microscope"></i>
                        <span>Diagnosis</span>
                    </div>
                    <i class="fas fa-chevron-down expand-icon"></i>
                </div>
                <div class="card-body">
                    <div class="card-content">
                        <div class="section">
                            <div class="section-title">
                                <i class="fas fa-tasks"></i>
                                Diagnostic Workup
                                <span class="badge badge-urgent">Essential Tests</span>
                            </div>
                            <div class="list-item">
                                <strong>1. MRI Spinal Cord with Gadolinium</strong>
                                <p>First-line test to confirm lesion, exclude compression, and characterize pattern</p>
                            </div>
                            <div class="list-item">
                                <strong>2. MRI Brain</strong>
                                <p>Detects disseminated lesions suggestive of MS or NMOSD</p>
                            </div>
                            <div class="list-item">
                                <strong>3. Serum Antibody Testing</strong>
                                <p>AQP4-IgG (for NMOSD) and MOG-IgG (for MOGAD)</p>
                            </div>
                            <div class="list-item">
                                <strong>4. CSF Analysis</strong>
                                <p>Pleocytosis, elevated protein, oligoclonal bands for inflammatory myelitis</p>
                            </div>
                        </div>

                        <div class="section">
                            <div class="section-title">
                                <i class="fas fa-search-plus"></i>
                                MRI Interpretation
                                <span class="badge badge-stable">Pattern Recognition</span>
                            </div>
                            <div class="treatment-grid">
                                <div class="treatment-card">
                                    <h4><i class="fas fa-layer-group"></i> MS Pattern</h4>
                                    <ul>
                                        <li>Short-segment lesions (1-2 segments)</li>
                                        <li>Peripheral location (<50% cord area)</li>
                                        <li>Brain lesions typical of demyelination</li>
                                    </ul>
                                </div>
                                <div class="treatment-card">
                                    <h4><i class="fas fa-arrows-alt-v"></i> NMOSD Pattern</h4>
                                    <ul>
                                        <li>Longitudinally extensive (≥3 segments)</li>
                                        <li>Central location (>50% cord area)</li>
                                        <li>Hiccups/nausea (area postrema)</li>
                                    </ul>
                                </div>
                                <div class="treatment-card">
                                    <h4><i class="fas fa-asterisk"></i> MOGAD Pattern</h4>
                                    <ul>
                                        <li>Longitudinal lesion with "H-sign"</li>
                                        <li>Conus involvement common</li>
                                        <li>Optic neuritis often simultaneous</li>
                                    </ul>
                                </div>
                                <div class="treatment-card">
                                    <h4><i class="fas fa-bug"></i> Infectious Pattern</h4>
                                    <ul>
                                        <li>Neutrophilic pleocytosis in CSF</li>
                                        <li>Systemic infection signs</li>
                                        <li>Specific PCR positive</li>
                                    </ul>
                                </div>
                            </div>
                        </div>

                        <div class="section">
                            <div class="section-title">
                                <i class="fas fa-clipboard-list"></i>
                                Diagnostic Criteria
                            </div>
                            <div class="criteria-box">
                                <div class="criteria-title">Transverse Myelitis Consortium Working Group (2002)</div>
                                <ul class="criteria-list">
                                    <li><strong>Inclusion:</strong> Bilateral sensory/motor/autonomic dysfunction, clear sensory level, progression 4hrs-21days</li>
                                    <li><strong>Exclusion:</strong> Compression, radiation, arterial thrombosis, connective tissue disease, infection</li>
                                </ul>
                            </div>
                            <div class="criteria-box" style="background: linear-gradient(135deg, #fce4ec 0%, #f8bbd0 100%); border-color: #f48fb1;">
                                <div class="criteria-title" style="color: #c2185b;">NMOSD Criteria (2015)</div>
                                <p style="margin-bottom: 0.5rem;"><strong>Core Clinical Characteristics:</strong></p>
                                <ul class="criteria-list">
                                    <li>Optic neuritis, acute myelitis, area postrema syndrome</li>
                                    <li>Acute brainstem syndrome, diencephalic/cerebral syndrome</li>
                                    <li><strong>With AQP4-IgG:</strong> 1 core characteristic + positive test</li>
                                    <li><strong>Without AQP4-IgG:</strong> 2+ core characteristics + MRI requirements</li>
                                </ul>
                            </div>
                            <div class="criteria-box" style="background: linear-gradient(135deg, #efebe9 0%, #d7ccc8 100%); border-color: #bcaaa4;">
                                <div class="criteria-title" style="color: #5d4037;">MOGAD Criteria (2023)</div>
                                <ul class="criteria-list">
                                    <li><strong>Core demyelinating event</strong> + <strong>MOG-IgG positive</strong></li>
                                    <li>Supporting features: bilateral optic neuritis, longitudinally extensive myelitis, conus lesion</li>
                                    <li>Exclusion of alternative diagnoses including MS</li>
                                </ul>
                            </div>
                        </div>

                        <div class="section">
                            <div class="section-title">
                                <i class="fas fa-not-equal"></i>
                                Differential Diagnosis
                                <span class="badge badge-caution">Critical Distinctions</span>
                            </div>
                            <div class="treatment-grid">
                                <div class="list-item">
                                    <div class="list-item-content">
                                        <strong>Compressive Myelopathy</strong>
                                        <p>Neoplasm, abscess, hematoma → Urgent surgical evaluation</p>
                                    </div>
                                </div>
                                <div class="list-item">
                                    <div class="list-item-content">
                                        <strong>Vascular Myelopathy</strong>
                                        <p>Anterior/posterior spinal artery occlusion → Sudden onset, no enhancement</p>
                                    </div>
                                </div>
                                <div class="list-item">
                                    <div class="list-item-content">
                                        <strong>Neoplastic Myelopathy</strong>
                                        <p>Intramedullary metastases → Persistent enhancement, CSF cytology</p>
                                    </div>
                                </div>
                                <div class="list-item">
                                    <div class="list-item-content">
                                        <strong>Paraneoplastic Myelopathy</strong>
                                        <p>Tract-specific changes → Antibody panel, tumor screening</p>
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
            </div>

            <!-- Treatment Card -->
            <div class="card fade-in" id="treatment-card">
                <div class="card-header treatment" onclick="toggleCard('treatment')">
                    <div style="display: flex; align-items: center;">
                        <i class="fas fa-syringe"></i>
                        <span>Treatment</span>
                    </div>
                    <i class="fas fa-chevron-down expand-icon"></i>
                </div>
                <div class="card-body">
                    <div class="card-content">
                        <div class="section">
                            <div class="section-title">
                                <i class="fas fa-bolt"></i>
                                Acute Management
                                <span class="badge badge-urgent">1st Line</span>
                            </div>
                            <div class="medication-item">
                                <span class="medication-name">IV Methylprednisolone</span>
                                <span class="medication-dose">1000 mg IV daily for 3-5 consecutive days</span>
                                <p><em>First-line for acute neurological deficits. May follow with oral taper (5-14 days)</em></p>
                            </div>
                            
                            <div class="section-title" style="margin-top: 1.5rem;">
                                <i class="fas fa-ambulance"></i>
                                Rescue Therapy
                                <span class="badge badge-caution">If No Response</span>
                            </div>
                            <div class="medication-item">
                                <span class="medication-name">Plasma Exchange (Plasmapheresis)</span>
                                <span class="medication-dose">7 exchanges every other day</span>
                                <p><em>42% show meaningful improvement vs 6% with sham</em></p>
                            </div>
                            <div class="medication-item">
                                <span class="medication-name">IV Immunoglobulin (IVIG)</span>
                                <span class="medication-dose">Consult specialist for dose</span>
                                <p><em>Alternative if plasma exchange unavailable (limited evidence)</em></p>
                            </div>
                        </div>

                        <div class="section">
                            <div class="section-title">
                                <i class="fas fa-procedures"></i>
                                Supportive Care
                                <span class="badge badge-stable">Essential</span>
                            </div>
                            <div class="treatment-grid">
                                <div class="treatment-card">
                                    <h4><i class="fas fa-lungs"></i> Respiratory Support</h4>
                                    <ul>
                                        <li>Monitor in cervical myelitis</li>
                                        <li>Maximal respiratory pressures, FVC</li>
                                        <li>Critical care involvement if ascending</li>
                                    </ul>
                                </div>
                                <div class="treatment-card">
                                    <h4><i class="fas fa-bladder"></i> Bladder Management</h4>
                                    <ul>
                                        <li>Catheterization for retention</li>
                                        <li>Urology referral for neurogenic bladder</li>
                                        <li>Anticholinergics or botulinum toxin</li>
                                    </ul>
                                </div>
                                <div class="treatment-card">
                                    <h4><i class="fas fa-muscle"></i> Spasticity Control</h4>
                                    <ul>
                                        <li>Stretching exercises</li>
                                        <li>Baclofen, tizanidine</li>
                                        <li>Botulinum toxin injections</li>
                                    </ul>
                                </div>
                                <div class="treatment-card">
                                    <h4><i class="fas fa-shield-alt"></i> DVT Prophylaxis</h4>
                                    <ul>
                                        <li>Subcutaneous heparin/enoxaparin</li>
                                        <li>Compression stockings/devices</li>
                                        <li>Early mobilization</li>
                                    </ul>
                                </div>
                            </div>
                        </div>

                        <div class="section">
                            <div class="section-title">
                                <i class="fas fa-shield-virus"></i>
                                Secondary Prevention
                                <span class="badge badge-stable">Condition-Specific</span>
                            </div>
                            
                            <div class="treatment-card" style="border-left: 4px solid #4caf50;">
                                <h4><i class="fas fa-question-circle"></i> Idiopathic TM</h4>
                                <p><strong>Observation</strong> - No preventive therapy if single event and no recurrence risk factors</p>
                            </div>

                            <div class="treatment-card" style="border-left: 4px solid #2196f3; background: linear-gradient(135deg, #e3f2fd 0%, #bbdefb 100%);">
                                <h4><i class="fas fa-brain"></i> High Risk for MS</h4>
                                <p><strong>Disease-Modifying Therapies</strong> for acute partial TM with typical brain MRI lesions</p>
                                <ul style="margin-top: 0.5rem;">
                                    <li>Interferon β, glatiramer acetate (for CIS)</li>
                                    <li>Follow AAN 2018 guidelines for MS therapy</li>
                                </ul>
                            </div>

                            <div class="treatment-card" style="border-left: 4px solid #f44336; background: linear-gradient(135deg, #ffebee 0%, #ffcdd2 100%);">
                                <h4><i class="fas fa-eye-dropper"></i> AQP4-IgG Positive (NMOSD)</h4>
                                <p><strong>Indefinite Immunosuppression</strong> - Targeted therapies preferred</p>
                                <div class="medication-item" style="background: #fff;">
                                    <span class="medication-name">Eculizumab</span>
                                    <span class="medication-dose">900 mg IV weekly ×4, then 1200 mg IV every 2 weeks</span>
                                    <p><em>Complement C5 inhibitor - Requires meningococcal vaccination</em></p>
                                </div>
                                <div class="medication-item" style="background: #fff;">
                                    <span class="medication-name">Ravulizumab</span>
                                    <span class="medication-dose">Dose by weight every 8 weeks</span>
                                    <p><em>Longer-acting C5 inhibitor - 98.6% relapse risk reduction</em></p>
                                </div>
                                <div class="medication-item" style="background: #fff;">
                                    <span class="medication-name">Inebilizumab</span>
                                    <span class="medication-dose">300 mg IV day 1, day 15, then every 6 months</span                                    <p><em>Anti-CD19 B-cell depletion - Premedication required</em></p>
                                </div>
                                <div class="medication-item" style="background: #fff;">
                                    <span class="medication-name">Satralizumab</span>
                                    <span class="medication-dose">120 mg SC loading, then every 4 weeks</span>
                                    <p><em>IL-6 receptor antagonist - Can be used as monotherapy</em></p>
                                </div>
                                <div class="medication-item" style="background: #fff;">
                                    <span class="medication-name">Rituximab (Alternative)</span>
                                    <span class="medication-dose">1000 mg IV every 2 weeks ×2, then every 6 months</span>
                                    <p><em>Anti-CD20 - 80% reduction in attack rates</em></p>
                                </div>
                            </div>

                            <div class="treatment-card" style="border-left: 4px solid #ff9800; background: linear-gradient(135deg, #fff3e0 0%, #ffe0b2 100%);">
                                <h4><i class="fas fa-dna"></i> MOG-IgG Positive (MOGAD)</h4>
                                <p><strong>Consider Immunosuppression</strong> after relapse or persistent antibodies</p>
                                <div class="medication-item" style="background: #fff;">
                                    <span class="medication-name">Azathioprine</span>
                                    <span class="medication-dose">2.5-3 mg/kg/day orally</span>
                                </div>
                                <div class="medication-item" style="background: #fff;">
                                    <span class="medication-name">Mycophenolate Mofetil</span>
                                    <span class="medication-dose">1-2 g/day in 2 divided doses</span>
                                </div>
                                <div class="medication-item" style="background: #fff;">
                                    <span class="medication-name">IVIG</span>
                                    <span class="medication-dose">Maintenance therapy reduces relapse risk</span>
                                </div>
                                <div class="medication-item" style="background: #fff;">
                                    <span class="medication-name">Tocilizumab</span>
                                    <span class="medication-dose">IL-6 receptor blockade - 80% decrease in relapse rate</span>
                                </div>
                            </div>
                        </div>

                        <div class="section">
                            <div class="section-title">
                                <i class="fas fa-viruses"></i>
                                Vaccination Considerations
                                <span class="badge badge-caution">Case-by-Case</span>
                            </div>
                            <div class="warning-box">
                                <i class="fas fa-info-circle warning-icon"></i>
                                <div class="warning-content">
                                    <strong>Vaccine-Associated TM</strong>
                                    <p>Avoid new vaccinations during acute disease activity. Specific vaccine should be avoided if previously temporally associated with TM. Balance risks vs benefits.</p>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
            </div>

            <!-- Follow-up Card -->
            <div class="card fade-in" id="followup-card">
                <div class="card-header followup" onclick="toggleCard('followup')">
                    <div style="display: flex; align-items: center;">
                        <i class="fas fa-chart-line"></i>
                        <span>Follow-up</span>
                    </div>
                    <i class="fas fa-chevron-down expand-icon"></i>
                </div>
                <div class="card-body">
                    <div class="card-content">
                        <div class="section">
                            <div class="section-title">
                                <i class="fas fa-heartbeat"></i>
                                Monitoring
                                <span class="badge badge-stable">Ongoing Care</span>
                            </div>
                            <div class="treatment-grid">
                                <div class="treatment-card">
                                    <h4><i class="fas fa-clock"></i> Immediate (1 week)</h4>
                                    <ul>
                                        <li>Respiratory function monitoring</li>
                                        <li>Complications of immobility</li>
                                        <li>Early rehabilitation initiation</li>
                                    </ul>
                                </div>
                                <div class="treatment-card">
                                    <h4><i class="fas fa-calendar-week"></i> Short-term (3 months)</h4>
                                    <ul>
                                        <li>DVT prophylaxis assessment</li>
                                        <li>Bladder function evaluation</li>
                                        <li>Spasticity management</li>
                                    </ul>
                                </div>
                                <div class="treatment-card">
                                    <h4><i class="fas fa-calendar-alt"></i> Long-term (6-12 months)</h4>
                                    <ul>
                                        <li>Neurological recovery plateau</li>
                                        <li>Symptom re-evaluation</li>
                                        <li>Pain, depression screening</li>
                                    </ul>
                                </div>
                                <div class="treatment-card">
                                    <h4><i class="fas fa-user-md"></i> High-Risk Patients</h4>
                                    <ul>
                                        <li>Every 3-6 months if on immunotherapy</li>
                                        <li>Monitor drug adverse effects</li>
                                        <li>Relapse surveillance</li>
                                    </ul>
                                </div>
                            </div>
                        </div>

                        <div class="section">
                            <div class="section-title">
                                <i class="fas fa-exclamation-triangle"></i>
                                Complications & Prognosis
                                <span class="badge badge-caution">Important Outcomes</span>
                            </div>
                            <div class="treatment-grid">
                                <div class="treatment-card" style="border-top: 4px solid #f44336;">
                                    <h4><i class="fas fa-brain"></i> Multiple Sclerosis</h4>
                                    <p><strong>High Risk:</strong> >80% develop MS within 10 years if brain MRI shows demyelinating lesions</p>
                                    <span class="badge badge-urgent">Long-term Risk</span>
                                </div>
                                <div class="treatment-card" style="border-top: 4px solid #ff9800;">
                                    <h4><i class="fas fa-male"></i> Motor Deficits</h4>
                                    <p><strong>Medium Risk:</strong> Residual weakness, spasticity requiring ongoing therapy</p>
                                    <span class="badge badge-caution">Variable Recovery</span>
                                </div>
                                <div class="treatment-card" style="border-top: 4px solid #4caf50;">
                                    <h4><i class="fas fa-bladder"></i> Bladder Dysfunction</h4>
                                    <p><strong>Medium Risk:</strong> Neurogenic bladder, incontinence, retention</p>
                                    <span class="badge badge-stable">Manageable</span>
                                </div>
                                <div class="treatment-card" style="border-top: 4px solid #2196f3;">
                                    <h4><i class="fas fa-band-aid"></i> Neuropathic Pain</h4>
                                    <p><strong>Medium Risk:</strong> Chronic pain syndromes requiring multimodal therapy</p>
                                    <span class="badge badge-stable">Treatable</span>
                                </div>
                            </div>
                        </div>

                        <div class="section">
                            <div class="section-title">
                                <i class="fas fa-chart-area"></i>
                                Recovery Patterns
                            </div>
                            <div class="treatment-grid">
                                <div class="treatment-card" style="background: linear-gradient(135deg, #e8f5e9 0%, #c8e6c9 100%);">
                                    <h4><i class="fas fa-arrow-up"></i> Acute Partial TM</h4>
                                    <ul>
                                        <li><strong>Good prognosis</strong> - most recover completely</li>
                                        <li>Recovery over weeks to months</li>
                                        <li>Majority of improvement in first 3 months</li>
                                        <li>Slower improvement may continue up to 1 year</li>
                                    </ul>
                                </div>
                                <div class="treatment-card" style="background: linear-gradient(135deg, #fff3e0 0%, #ffe0b2 100%);">
                                    <h4><i class="fas fa-arrows-alt-v"></i> Complete/Longitudinally Extensive TM</h4>
                                    <ul>
                                        <li><strong>Variable prognosis</strong></li>
                                        <li>~33% complete/near-complete recovery</li>
                                        <li>~33% moderate residual deficits</li>
                                        <li>~33% severe disability</li>
                                        <li>Recovery may continue up to 2 years</li>
                                    </ul>
                                </div>
                            </div>
                        </div>

                        <div class="section">
                            <div class="section-title">
                                <i class="fas fa-user-shield"></i>
                                Patient Education
                                <span class="badge badge-stable">Essential</span>
                            </div>
                            <div class="warning-box" style="background: linear-gradient(135deg, #e8eaf6 0%, #c5cae9 100%); border-color: #9fa8da;">
                                <i class="fas fa-info-circle warning-icon" style="color: #3f51b5;"></i>
                                <div class="warning-content">
                                    <strong>Advise patients to contact neurologist immediately if experiencing:</strong>
                                    <ul style="margin-top: 0.5rem; padding-left: 1rem;">
                                        <li>New motor weakness</li>
                                        <li>Pain or sensory disturbances</li>
                                        <li>Bladder/bowel dysfunction</li>
                                        <li>Changes in ambulatory ability</li>
                                    </ul>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
            </div>

            <div class="footer">
                <p><strong>Disclaimer:</strong> This algorithm is for educational purposes based on BMJ Best Practice Guidelines (2025). Clinical decisions should be individualized.</p>
                <p>Always consult specialist neurology services for diagnostic confirmation and management.</p>
                <p><a href="https://bestpractice.bmj.com/topics/en-gb/1147" target="_blank">View Full BMJ Best Practice Topic</a> | <a href="https://www.brainandspine.org.uk/transverse-myelitis" target="_blank">Brain & Spine Foundation</a></p>
            </div>
        </main>
    </div>

    <script>
        // Card toggle functionality
        function toggleCard(cardId) {
            const card = document.getElementById(cardId + '-card');
            const isExpanded = card.classList.contains('expanded');
            
            // Close all cards
            document.querySelectorAll('.card').forEach(c => c.classList.remove('expanded'));
            
            // Toggle current card
            if (!isExpanded) {
                card.classList.add('expanded');
                updateProgress(cardId);
                
                // Smooth scroll to card
                setTimeout(() => {
                    card.scrollIntoView({ behavior: 'smooth', block: 'start' });
                }, 100);
            }
        }

        // Progress tracking
        function updateProgress(activeStep) {
            const steps = ['assessment', 'diagnosis', 'treatment', 'followup'];
            const progressItems = document.querySelectorAll('.progress-item');
            
            progressItems.forEach((item, index) => {
                const step = steps[index];
                item.classList.remove('active', 'completed');
                
                if (step === activeStep) {
                    item.classList.add('active');
                } else if (steps.indexOf(step) < steps.indexOf(activeStep)) {
                    item.classList.add('completed');
                }
            });
        }

        // Progress item click handler
        document.querySelectorAll('.progress-item').forEach(item => {
            item.addEventListener('click', () => {
                const step = item.dataset.step;
                toggleCard(step);
            });
        });

        // Initialize with assessment expanded
        document.addEventListener('DOMContentLoaded', () => {
            toggleCard('assessment');
            
            // Add fade-in animation to cards
            const observer = new IntersectionObserver((entries) => {
                entries.forEach(entry => {
                    if (entry.isIntersecting) {
                        entry.target.style.opacity = '1';
                        entry.target.style.transform = 'translateY(0)';
                    }
                });
            });

            document.querySelectorAll('.card').forEach(card => {
                card.style.opacity = '0';
                card.style.transform = 'translateY(20px)';
                card.style.transition = 'opacity 0.6s ease, transform 0.6s ease';
                observer.observe(card);
            });
        });

        // Smooth scrolling for internal links
        document.querySelectorAll('a[href^="#"]').forEach(anchor => {
            anchor.addEventListener('click', function (e) {
                e.preventDefault();
                const target = document.querySelector(this.getAttribute('href'));
                if (target) {
                    target.scrollIntoView({ behavior: 'smooth' });
                }
            });
        });

        // Keyboard navigation
        document.addEventListener('keydown', (e) => {
            const steps = ['assessment', 'diagnosis', 'treatment', 'followup'];
            const currentIndex = steps.findIndex(step => {
                const card = document.getElementById(step + '-card');
                return card.classList.contains('expanded');
            });
            
            if (e.key === 'ArrowDown' && currentIndex < steps.length - 1) {
                e.preventDefault();
                toggleCard(steps[currentIndex + 1]);
            } else if (e.key === 'ArrowUp' && currentIndex > 0) {
                e.preventDefault();
                toggleCard(steps[currentIndex - 1]);
            }
        });

        // Pulse animation for urgent items
        document.querySelectorAll('.badge-urgent').forEach(badge => {
            badge.addEventListener('mouseenter', () => {
                badge.parentElement.classList.add('pulse');
            });
            badge.addEventListener('mouseleave', () => {
                badge.parentElement.classList.remove('pulse');
            });
        });

        // Copy medication info to clipboard
        document.querySelectorAll('.medication-item').forEach(item => {
            item.addEventListener('click', () => {
                const text = item.textContent.trim();
                navigator.clipboard?.writeText(text).then(() => {
                    const originalBg = item.style.background;
                    item.style.background = '#e8f5e9';
                    item.style.border = '2px solid #4caf50';
                    setTimeout(() => {
                        item.style.background = originalBg;
                        item.style.border = '1px solid #c5e1a5';
                    }, 1000);
                });
            });
        });
    </script>
</body>
</html>